Novel Aspects Pertaining to the Relationship of Waldenstrom's Macroglobulinemia, IgM Monoclonal Gammopathy of Undetermined Significance, Polyclonal Gammopathy, and Hypoglobulinemia

被引:12
作者
McMaster, Mary L. [1 ]
Kristinsson, Sigurdur Y. [2 ,3 ]
Turesson, Ingemar [4 ]
Bjorkholm, Magnus [2 ,3 ]
Landgren, Ola [1 ,5 ]
机构
[1] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA
[2] Karolinska Univ Hosp Solna, Div Hematol, Dept Med, Stockholm, Sweden
[3] Karolinska Inst, Stockholm, Sweden
[4] Malmo Univ Hosp, Sect Hematol, Dept Med, Malmo, Sweden
[5] NCI, Med Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
关键词
Genetic susceptibility; Hypergammaglobulinemia; IgM; Precursor disease; NON-HODGKIN-LYMPHOMA; LONG-TERM; ADULT-POPULATION; RISK; PREVALENCE; DISORDERS; FAMILIES; EVOLUTION;
D O I
10.3816/CLM.2009.n.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Waldenstrom's macroglobulinemia (WM) is associated with a precursor condition, monoclonal gammopathy of undetermined significance (MGUS) of immunoglobulin-M (IgM) type. The etiology of these conditions is unknown. Recent studies at the population level have provided new data regarding familial aggregation of these disorders and other B-cell malignancies. Studies of familial clusters of WM have demonstrated an increased frequency of IgM MGUS compared with the general population and have provided new data suggesting that the phenotypic spectrum might also include polyclonal gammopathy and hypoglobulinemia. While the preponderance of immunoglobulin abnormalities in relatives of WM cases involves IgM, other immunoglobulin types (IgG and IgA) might also be affected. Large collaborative studies are needed to confirm these findings, which present an opportunity to define the earliest lesion(s) in the WM oncogenic pathway.
引用
收藏
页码:19 / 22
页数:4
相关论文
共 25 条
  • [1] Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece
    Anagnostopoulos, A
    Evangelopoulou, A
    Sotou, D
    Gika, D
    Mitsibounas, D
    Dimopoulos, MA
    [J]. ANNALS OF HEMATOLOGY, 2002, 81 (07) : 357 - 361
  • [2] AXELSSON U, 1966, ACTA MED SCAND, V179, P235
  • [3] Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: Proposal for a common prognostic scoring system
    Baldini, L
    Goldaniga, M
    Guffanti, A
    Broglia, C
    Cortelazzo, S
    Rossi, A
    Morra, E
    Colombi, M
    Callea, V
    Pogliani, E
    Ilariucci, F
    Luminari, S
    Morel, P
    Merlini, G
    Gobbi, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (21) : 4662 - 4668
  • [4] Berger R., 2001, World Health Organization Classification of Tumours Tumors of Haematopoietic and Lymphoid Tissues, P132
  • [5] Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly
    Cohen, HJ
    Crawford, J
    Rao, MK
    Pieper, CF
    Currie, MS
    [J]. AMERICAN JOURNAL OF MEDICINE, 1998, 104 (05) : 439 - 444
  • [6] Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus
    Giordano, Thomas P.
    Henderson, Louise
    Landgren, Ola
    Chiao, Elizabeth Y.
    Kramer, Jennifer R.
    El-Serag, Hashem
    Engels, Eric A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (18): : 2010 - 2017
  • [7] Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database
    Goldin, LR
    Pfeiffer, RM
    Li, XJ
    Hemminki, K
    [J]. BLOOD, 2004, 104 (06) : 1850 - 1854
  • [8] Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples
    Goldin, LR
    Landgren, O
    McMaster, ML
    Gridley, G
    Hemminki, K
    Li, XJ
    Mellemkjaer, L
    Olsen, JH
    Linet, MS
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (10) : 2402 - 2406
  • [9] Groves FD, 1998, CANCER-AM CANCER SOC, V82, P1078
  • [10] Prevalence of monoclonal gammopathy of undetermined significance: Study of 52,802 persons in Nagasaki city, Japan
    Iwanaga, Masako
    Tagawa, Masuko
    Tsukasaki, Kunihiro
    Kamihira, Shimera
    Tomonaga, Masao
    [J]. MAYO CLINIC PROCEEDINGS, 2007, 82 (12) : 1474 - 1479